Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Industry Focus

Industry Focus

Edit Profile
Episodes
1101
Followers
Listens
70082
×  

Follow This Show

Stay in the know about new episodes and updates.
Featured Host
Healthcare, technology, energy, consumer goods, and more. If you're looking for deeper insights on today’s top industries then this podcast is for you.

On-Demand Episodes

Whether you’re a first-time stock buyer or seasoned Fool with years of experience in the market, stock screens can be a powerful tool of discovery for any investor. We cover the basics of creating a stock screen, what metrics to employ,... more
Play Now

Here’s a roundup of the past week’s news from Wells Fargo, Goldman Sachs, Morgan Stanley, and SunTrust.
Play Now

Looking for some new stocks for your watch list? We talk about why we're excited about Paylocity, Hubspot, and AppFolio.
Play Now

We tackle a host of news items in Oil and Gas including; British Columbia halts development of the TransMountain pipeline, consumers face high prices at the pumps, and China’s new intelligent highway will be able to charge electric... more
Play Now

Alkermes’ ALKS-5461 gets a do-over, Celldex's lead drug is a bust, and the good and bad of Johnson & Johnson's Q1 earnings report. Thanks to Blooom for supporting Industry Focus. Get a month free with blooom401k.com/fool and code... more
Play Now

Down about 20% from its all-time highs, Ulta stock has seen dampened investor enthusiasm after an otherwise amazing 10-year run as a public company. Listener Joseph wants to know why Ulta stock has struggled as Estee Lauder, another... more
Play Now

Now that the “big four” U.S. banks have reported earnings, let’s take a look to see what investors need to know.
Play Now

There have always been rumors of a paid version of Facebook. Recent comments from Mark Zuckerberg and Sheryl Sandberg prove its something management has been thinking about, but what would it actually look like? Slack: Where work... more
Play Now

NV5 and Pattern Energy Group have both been previously pitched on the show. And, both stocks have had a tumultuous time over the past few months. We discuss if recent events have changed the fundamental thesis for each.
Play Now

Biogen misses out on a huge deal that Novartis completed with AveXis. Plus, Incyte's phase 3 implosion, and what it means for immuno-oncology more broadly.
Play Now

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled